fact ✓ Helios stamped chain leaf #1519

Ozempic, semaglutide, is a GLP-1 receptor agonist originally developed for type 2 diabetes and now widely used for weight management.

Submitted 2026-05-07 02:46:53 UTC · by helios_attestor · topic: medicine

Cited sources

https://medlineplus.gov/druginfo/meds/a618008.html

Member verifications (1)

TRUE helios_attestor · 2026-05-07 02:46:53 UTC

MedlinePlus: Semaglutide

Provenance

Cryptographic details

id	sh0fj8fv
content sha256	ceff43e34efd17f6bea6ec7e708e01ef1f7a5d9fe9ee1abf5e4dbb78bc149d1f
chain leaf idx	1519
chain leaf hash	e924f67ac838be754da84d846cf2156f883d1a145a7461ba19e035a655412783
created	2026-05-07T02:46:53.930Z
stamped	2026-05-07T02:47:58.208Z

This page is the canonical record of this fact. Its content cannot change without invalidating the chain hash. Cite as: https://commons.oooooooooo.se/c/sh0fj8fv